Affinity Partners is an American private equity and investment firm founded in 2021 by Jared Kushner. Based in Miami, Florida, the firm raises capital primarily from Middle Eastern sovereign wealth funds and invests in growth-stage companies across a wide range of sectors in the United States and Israel.
Deal activity increased 200% year-over-year (3 deals in the last 12 months). Average disclosed round size is $152.3M (across 31 rounds with reported amounts).
Portfolio
26
Fund Size
$3B
Top Stage
Unknown
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
31 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Whoop | Series G | $575M | Mar 2026 |
| TTRexBio, Inc. | Series C | $50M | Jan 2026 |
| Whoop | Series G | $575M | Jan 2026 |
 Climb Bio | Unknown | $110M | Jan 2026 |
| AAvere Therapeutics | Unknown | $320M | Jan 2026 |
 First Tracks | Unknown | $80M | Jan 2026 |
 EON | Series D | $300M | Dec 2025 |
| DDosen | Pre-Seed | $2.3M | Apr 2025 |
 Eon | Series D | $300M | Jan 2025 |
 QXO | Unknown | $620M | Jan 2024 |
 eGym | Series F | $225M | Jul 2023 |
 Unybrands | Series C | $75M | Apr 2022 |
 dubizzle | Series F | $200M | Jan 2022 |
| UUnybrands Operations Ltd | Unknown | $75M | Jan 2022 |
| Unybrands | Series B | $75M | Jan 2022 |
| KKurome Therapeutics | Series A | $15M | Jun 2021 |
| Climb Bio | Series B | $60M | May 2021 |
 Hummingbird Bioscience | Series C | $125M | May 2021 |
 Kira Pharmaceuticals | Series B | $53.5M | Jan 2021 |
| UUptake Medical | Seed | $35M | Dec 2011 |
 ValenTx | Series B | $22M | Sep 2009 |
 RespiCardia | Series B | $21M | Jan 2008 |
| AAblation Frontiers | Series C | $21.8M | Jan 2007 |
| AArbor Surgical Technologies | Series B | $20M | Aug 2005 |
 Hummingbird Bioscience | Series C | $125M | — |
Page 1 of 2
Top Co-Investors
Polaris Partners5 shared
Ally Bridge Group5 shared
Cormorant Asset Management3 shared
Redmile Group3 shared
RA Capital Management3 shared
Day One Ventures2 shared
Gil Capital2 shared
BOND2 shared
Lightspeed Venture Partners2 shared
Greenoaks Capital2 shared
Sequoia Capital2 shared
Bayern Kapital2 shared
Delos Capital2 shared
SV Health Investors2 shared
Alexandria Venture Investments2 shared
Balyasny Asset Management2 shared
Pfizer Ventures2 shared
Eli Lilly and Company2 shared
Accomplice2 shared
Mubadala Investment Company2 shared
Last updated: 20 October 2026